It seems likely that short-term gains are made at the expense of increasing problems such as antibiotic resistance. The only alternatives are to ensure practitioners have the skills to appraise medicine promotion activities or to more stringently control pharmaceutical promotional activities.
It seems probable that short-term gains come at the cost of escalating problems such as antibiotic resistance. One possible solution is to equip practitioners with the skills necessary to evaluate the effects of medicine promotion efforts, or to implement more stringent regulations on pharmaceutical promotional activities.